Action guide for community pharmacist in patients with hypertension and cardiovascular risk. Consensus document (condensed version).;Guía de actuación para el farmacéutico comunitario en pacientes con hipertensión arterial y riesgo cardiovascular. Documento de consenso (versión resumida)

Hipertension y Riesgo Vascular

Volumn 28, Issue 5-6, 2011, Pages 169-181

  Sabater Hernandez D ^a,g   de la Sierra, A ^b,h   Bellver Monzo O ^c,i   Divison J A ^d,j   Gorostidi, M ^e,j   Perseguer Torregosa, Z ^c,k   Segura, J ^f,j   Tous, S ^c,k  

^a UNIVERSITY OF GRANADA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c Centro de Salud de Casas Ibáñez ^*

^d Centro de Salud de Casas Ibanez   (Spain)

^e HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^f HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^g Sociedad Española de Farmacia Comunitaria SEFAC   (Spain)

^h Lucha contra la Hipertensión Arterial   (Spain)

ⁱ Grupo de Hipertensión y riesgo vascular de SEFAC   (Spain)

^j SEH LELHA   (Spain)

^k SEFAC   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; HUMAN; HYPERTENSION; PHARMACIST; PRACTICE GUIDELINE;

EID: 82955232915     PISSN: 18891837     EISSN: 19894805     Source Type: Journal    
DOI: 10.1016/j.hipert.2011.09.001     Document Type: Article

References (33)

1. Graham I., Atar D., Borch-Johnsen K., Boysen G., Burell G., Cifkova R., et al. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007, 14(Suppl 2):S1-S113.
2. Mancia G., Laurent S., Agabiti-Rosei E., Ambrosioni E., Burnier M., Caulfield M.J., et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009, 27:2121-2158.
3. Mancia G., De Backer G., Dominiczak A., Cifkova R., Fagard R., Germano G., et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25:1105-1187.
4. D'Agostino R.B., Grundy S., Sullivan L.M., Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001, 286:180-187.
5. Marrugat J., Subirana I., Comin E., Cabezas C., Vila J., Elosua R., et al. Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study. J Epidemiol Community Health 2007, 61:40-47.
6. Maiques Galán A., Villar álvarez F., Brotons Cuixart C., Torcal Laguna J., Orozco-Beltrán D., Navarro Pérez J., et al. Recomendaciones preventivas cardiovasculares. Aten Primaria 2007, 39(Suppl 3):15-26.
7. O'Brien E., Pickering T., Asmar R., Myers M., Parati G., Staessen J., et al. Working Group on Blood Pressure Monitoring of the European Society of Hypertension International Protocol for validation of blood pressure measuring devices in adults. Blood Press Monit 2002, 7:3-17.
8. Sabater-Hernández D., Sánchez-Villegas P., Lacampa P., Artiles-Campelo A., Jorge-Rodríguez M.E., Faus M.J. Evaluation of the hypertensive state in treated patients: selection of appropriate blood pressure measurements per visit to the community pharmacy. Blood Press Monit 2011, 16:103-110.
9. Sabater-Hernández D., Azpilicueta I., Sanchez-Villegas P., Amariles P., Baena M.I., Faus M.J. Clinical value of blood pressure measurement in the community pharmacy. Pharm World Sci 2010, 32:552-558.
10. Sega R., Facchetti R., Bombelli M., Cesana G., Corrao G., Grassi G., et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005, 111:1777-1783.
11. Fagard R.H., Van Den Broeke C., De Cort P. Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice. J Hum Hypertens 2005, 19:801-807.
12. Verberk W.J., Kroon A.A., Kessels A.G., De Leeuw P.W. Home blood pressure measurement: a systematic review. J Am Coll Cardiol 2005, 46:743-751.
13. De la Sierra A., Gorostidi M., Marin R., Redon J., Banegas J.R., Armario P., et al. Evaluación y tratamiento de la hipertensión arterial en España. Med Clin (Barc) 2008, 131:104-116.
14. Sendra-Lillo J., Sabater-Hernández D., Sendra-Ortola A., Martinez-Martinez F. Comparison of the white-coat effect in community pharmacy versus the physician's office: the Palmera study. Blood Press Monit 2011, 16:62-66.
15. Sabater-Hernández D, De la Sierra A, Sánchez-Villegas P, Baena M, Amariles P, Faus M. Magnitude of the white-coat effect in the community pharmacy setting. The MEPAFAR study. Am J Hypertens. 2011;24:887-92.
16. Parati G., Pickering T.G. Home blood-pressure monitoring: US and European consensus. Lancet 2009, 373:876-878.
17. Parati G., Stergiou G.S., Asmar R., Bilo G., de Leeuw P., Imai Y., et al. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens 2008, 26:1505-1526.
18. Pickering T.G., Miller N.H., Ogedegbe G., Krakoff L.R., Artinian N.T., Goff D. Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association. American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension 2008, 52:10-29.
19. Parati G., Stergiou G.S., Asmar R., Bilo G., de Leeuw P., Imai Y., et al. European Society of Hypertension Practice Guidelines for home blood pressure monitoring. J Hum Hypertens 2010, 24:779-785.
20. Mallion J.M., Baguet J.P., Mancia G. European Society of Hypertension Scientific Newsletter: Clinical value of ambulatory blood pressure monitoring. J Hypertens 2006, 24:2327-2330.
21. Sabater-Hernández D., Fikri-Benbrahim O., Faus M.J. Utilidad de la monitorización ambulatoria de la presión arterial en la toma de decisiones clínicas. Med Clin (Barc) 2010, 135:23-29.
22. Vanelli M., Pedan A., Liu N., Hoar J., Messier D., Kiarsis K. The role of patient inexperience in medication discontinuation: a retrospective analysis of medication nonpersistence in seven chronic illnesses. Clin Ther 2009, 31:2628-2652.
23. Dickinson H.O., Mason J.M., Nicolson D.J., Campbell F., Beyer F.R., Cook J.V., et al. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials. J Hypertens 2006, 24:215-233.
24. Lobos J.M., Royo-Bordonada M.A., Brotons C., Alvarez-Sala L., Armario P., Maiques A., et al. Guía europea de Prevención Cardiovascular en la Práctica Clínica. Adaptación española del Comité Español Interdisciplinario para la Prevención Cardiovascular 2008. Rev Esp Salud Pública 2008, 82:581-616.
25. Burke J.M., Miller W.A., Spencer A.P., Crank C.W., Adkins L., Bertch K.E., et al. Clinical pharmacist competencies. Pharmacotherapy 2008, 28:806-815.
26. Tercer Consenso de Granada sobre problemas relacionados con los medicamentos y resultados negativos asociados a la medicación. Ars Pharm 2007, 48:5-17. Comité de Consenso.
27. Weber C.A., Ernst M.E., Sezate G.S., Zheng S., Carter B.L. Pharmacist-physician comanagement of hypertension and reduction in 24-hour ambulatory blood pressures. Arch Intern Med 2010, 170:1634-1639.
28. Tobari H., Arimoto T., Shimojo N., Yuhara K., Noda H., Yamagishi K., et al. Physician-pharmacist cooperation program for blood pressure control in patients with hypertension: a randomized-controlled trial. Am J Hypertens 2010, 23:1144-1152.
29. Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens 2006, 19:1190-1196.
30. Rodríguez-Chamorro M.A., García-Jiménez E., Busquets A., Rodríguez-Chamorro A., Pérez E.M., Faus M.J., et al. Herramientas para identificar el incumplimiento farmacoterapéutico desde la farmacia comunitaria. Pharm Care Esp 2009, 11:183-191.
31. Morrison A., Wertheimer A., Berger M. Interventions to improve antihypertensive drug adherence:a quantitaive review of trials. Formulary 2000, 35:234-255.
32. Stergiou G., Mengden T., Padfield P.L., Parati G., O'Brien E. Self monitoring of blood pressure at home. BMJ 2004, 329:870-871.
33. Cappuccio F.P., Kerry S.M., Forbes L., Donald A. Blood pressure control by home monitoring: meta-analysis of randomised trials. BMJ 2004, 329:145.